SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-025967
Filing Date
2022-05-12
Accepted
2022-05-12 16:26:48
Documents
50
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_cormedix.htm   iXBRL 10-Q 796735
2 CERTIFICATION f10q0322ex31-1_cormedix.htm EX-31.1 10914
3 CERTIFICATION f10q0322ex31-2_cormedix.htm EX-31.2 10948
4 CERTIFICATION f10q0322ex32-1_cormedix.htm EX-32.1 3662
5 CERTIFICATION f10q0322ex32-2_cormedix.htm EX-32.2 3768
  Complete submission text file 0001213900-22-025967.txt   4121724

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crmd-20220331.xsd EX-101.SCH 37565
7 XBRL CALCULATION FILE crmd-20220331_cal.xml EX-101.CAL 26959
8 XBRL DEFINITION FILE crmd-20220331_def.xml EX-101.DEF 173505
9 XBRL LABEL FILE crmd-20220331_lab.xml EX-101.LAB 356672
10 XBRL PRESENTATION FILE crmd-20220331_pre.xml EX-101.PRE 184833
44 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_cormedix_htm.xml XML 567827
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34673 | Film No.: 22918250
SIC: 2834 Pharmaceutical Preparations